We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
167 result(s) found, displaying 71 to 80
-
Prescription medicine registrationActive ingredients: semaglutide.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 500 IU powder and solvent for solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 2000 IU powder and solvent for solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for REFIXIA nonacog beta pegol 1000 IU powder and solvent for solution for injection.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OZEMPIC 1 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen.
-
Australian public assessment report (AusPar)Australian Public Assessment Report for insulin degludec/liraglutide
-
Cancellation by sponsorRequested by Novo Nordisk Pharmaceuticals Pty Ltd
-
Cancellation by sponsorRequested by Novo Nordisk Pharmaceuticals Pty Ltd
-
Cancellation by sponsorRequested by Novo Nordisk Pharmaceuticals Pty Ltd